Company LumiraDx Limited

Equities

LMDXF

KYG5709L1095

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 03:58:27 2024-05-21 pm EDT			5-day change	1st Jan Change
0.0175 ^USD	-3.85%		-3.31%	-72.18%

May. 20	U.K. Competition Watchdog Weighs Potential Impact of Roche-LumiraDx	DJ
Jan. 08	Top Midday Decliners	MT

LumiraDx Limited is a point of care diagnostic company. The Company is focused on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need. The Company has developed and launched the LumiraDx Platform, which is an integrated system comprised of a small, versatile Instrument, low-cost microfluidic Test Strips, and seamless, secure digital connectivity. The Company offers a menu of lab comparable tests on a single portable platform, with more than 30 assays on the market and in various stages of development, covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders. It also supports laboratory testing in an accessible high-throughput format to leverage molecular laboratory operations. Its diagnostic testing solutions are being deployed globally by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools and others.

Number of employees: 1,210

USD in Million	2021	Weight	2022	Weight	Delta
Medical Diagnostic Products 98.6 %	416	98.6 %	251	98.6 %	-39.61%
Platform Services 1.4 %	6	1.4 %	3	1.4 %	-40.01%

USD in Million	2021	Weight	2022	Weight	Delta
United States 54.8 %	251	59.5 %	140	54.8 %	-44.35%
Italy 19.3 %	66	15.6 %	49	19.3 %	-25.07%
United Kingdom 8.7 %	56	13.4 %	22	8.7 %	-60.45%
Other 7.8 %	1	0.1 %	20	7.8 %	+3,070.32%
Colombia 4.3 %	12	2.9 %	11	4.3 %	-9.52%
Germany 3.4 %	16	3.9 %	9	3.4 %	-46.88%
Sweden 1.5 %	7	1.7 %	4	1.5 %	-43.87%

Managers	Title	Age	Since
Ron Zwanziger CEO	Chief Executive Officer	70	13-12-31
Dave Scott FOU	Founder	67	13-12-31
Dorian LeBlanc DFI	Director of Finance/CFO	49	16-10-31
Thomas Quinlan PRN	Corporate Officer/Principal	61	17-09-30
Veronique Ameye LAW	General Counsel	47	15-01-31
Peter Welch PRN	Corporate Officer/Principal	-	-
David Walton PRN	Corporate Officer/Principal	70	14-07-31
Nigel Lindner PRN	Corporate Officer/Principal	67	14-11-30

Members of the board	Title	Age	Since
Dave Scott FOU	Founder	67	13-12-31
Ron Zwanziger CEO	Chief Executive Officer	70	13-12-31
Troyen Brennan BRD	Director/Board Member	69	16-10-31
Jerome McAleer FOU	Founder	68	13-12-31
Lok Chung Chan BRD	Director/Board Member	73	20-08-31
Donald Berwick BRD	Director/Board Member	77	17-12-31
Julia Lurene BRD	Director/Board Member	64	16-10-31
Bruce Keogh BRD	Director/Board Member	69	17-12-31
George Neble BRD	Director/Board Member	67	20-06-30
Lu Huang BRD	Director/Board Member	50	18-09-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	164,321,766	162,678,548 ( 99.00 %)	0	99.00 %

Name	Equities	%	Valuation
Ron Zwanziger 27.35 %	42,180,049	27.35 %	843 601 $
Morningside Group Ltd. 17.81 %	27,464,978	17.81 %	549 300 $
Bill & Melinda Gates Foundation 9.263 %	14,285,714	9.263 %	285 714 $
Bill Umphrey 8.512 %	13,128,350	8.512 %	262 567 $
Dave Scott 6.919 %	10,670,522	6.919 %	213 410 $
Senvest Management LLC 5.234 %	8,072,781	5.234 %	161 456 $
Jerome McAleer 5.017 %	7,736,677	5.017 %	154 734 $
Petrichor Healthcare Capital Management LP 3.671 %	5,660,848	3.671 %	113 217 $
Anne M Umphrey 0.2739 %	422,486	0.2739 %	8 450 $
BDO Wealth Advisors LLC 0.1207 %	186,220	0.1207 %	3 724 $

Name	Equities	%	Valuation
Ron Zwanziger -	37,184,803	-	743 696 $
Morningside Group Ltd. -	24,296,120	-	485 922 $
Dave Scott -	10,670,522	-	213 410 $
Jerome McAleer -	7,736,677	-	154 734 $
Anne M Umphrey -	6,812,266	-	136 245 $
Senvest Management LLC -	5,575,474	-	111 509 $
Bill & Melinda Gates Foundation Trust (Investment Management) -	5,574,059	-	111 481 $
Bill Umphrey -	5,363,256	-	107 265 $
Petrichor Healthcare Capital Management LP -	3,195,284	-	63 906 $
David Walton -	902,122	-	18 042 $

Name	Equities	%	Valuation
CVS HEALTH CORPORATION -	5,352,106	-	535 $
Goldman Sachs & Co. LLC -	215,680	-	22 $
Ancora Alternatives LLC -	15,470	-	2 $
Bloom Tree Partners LLC -	10,255	-	1 $
Steward Partners Investment Advisory LLC -	21	-	0 $

LumiraDX Ltd.

221 crescent Street 5th Floor

02543, Waltham

http://www.lumiradx.com

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
LUMIRADX LIMITED	-72.18%	6.28M
THERMO FISHER SCIENTIFIC	+11.18%	225B
DANAHER CORPORATION	+15.22%	197B
INTUITIVE SURGICAL, INC.	+19.19%	143B
BOSTON SCIENTIFIC CORPORATION	+30.89%	111B
SIEMENS HEALTHINEERS AG	+1.56%	64.72B
EDWARDS LIFESCIENCES CORPORATION	+18.48%	54.44B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+5.12%	51.06B
AGILENT TECHNOLOGIES, INC.	+10.53%	45.03B
GE HEALTHCARE TECHNOLOGIES INC.	+5.98%	37.4B

Other Advanced Medical Equipment & Technology